Genome instability in multiple myeloma
CJ Neuse, OC Lomas, C Schliemann, YJ Shen… - Leukemia, 2020 - nature.com
Multiple myeloma (MM) is an incurable plasma cell malignancy characterized by clonal
proliferation of plasma cells and a heterogenous genomic landscape. Copy number and …
proliferation of plasma cells and a heterogenous genomic landscape. Copy number and …
Genome instability in multiple myeloma: Facts and factors
AY Aksenova, AS Zhuk, AG Lada, IV Zotova… - Cancers, 2021 - mdpi.com
Simple Summary Multiple myeloma is an incurable blood cancer caused by the malignant
transformation of immunoglobulin-producing plasma cells. The mechanisms leading to the …
transformation of immunoglobulin-producing plasma cells. The mechanisms leading to the …
The role of tumor microenvironment in genomic instability of malignant tumors
FG Sonugür, H Akbulut - Frontiers in genetics, 2019 - frontiersin.org
Genomic instability is an essential feature of cancer cells. The somatic mutation theory
suggests that along with inherited ones, the changes in DNA caused by environmental …
suggests that along with inherited ones, the changes in DNA caused by environmental …
[HTML][HTML] Comprehensive characterization of the mutational landscape in multiple myeloma cell lines reveals potential drivers and pathways associated with tumor …
V Vikova, M Jourdan, N Robert, G Requirand… - Theranostics, 2019 - ncbi.nlm.nih.gov
Human multiple myeloma tumor cell lines (HMCLs) have been a cornerstone of research in
multiple myeloma (MM) and have helped to shape our understanding of molecular …
multiple myeloma (MM) and have helped to shape our understanding of molecular …
Deciphering the chronology of copy number alterations in Multiple Myeloma
A Aktas Samur, S Minvielle, M Shammas… - Blood cancer …, 2019 - nature.com
Multiple myeloma (MM) and its precursor condition MGUS are characterized by
chromosomal aberrations. Here, we comprehensively characterize the order of occurrence …
chromosomal aberrations. Here, we comprehensively characterize the order of occurrence …
Genomic complexity of multiple myeloma and its clinical implications
S Manier, KZ Salem, J Park, DA Landau… - Nature reviews Clinical …, 2017 - nature.com
Multiple myeloma (MM) is a genetically complex disease that evolves from pre-malignant
stages, such as monoclonal gammaopathy of undetermined significance and smouldering …
stages, such as monoclonal gammaopathy of undetermined significance and smouldering …
A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value
BA Walker, PE Leone, L Chiecchio… - Blood, The Journal …, 2010 - ashpublications.org
To obtain a comprehensive genomic profile of presenting multiple myeloma cases we
performed high-resolution single nucleotide polymorphism mapping array analysis in 114 …
performed high-resolution single nucleotide polymorphism mapping array analysis in 114 …
Malignant clonal evolution drives multiple myeloma cellular ecological diversity and microenvironment reprogramming
Y Liang, H He, W Wang, H Wang, S Mo, R Fu, X Liu… - Molecular Cancer, 2022 - Springer
Background Multiple myeloma (MM) is a heterogeneous disease with different patterns of
clonal evolution and a complex tumor microenvironment, representing a challenge for …
clonal evolution and a complex tumor microenvironment, representing a challenge for …
MYC dysregulation in the progression of multiple myeloma
K Misund, N Keane, CK Stein, YW Asmann, G Day… - Leukemia, 2020 - nature.com
Multiple myeloma (MM) is a plasma cell malignancy preceded by a premalignant stage,
named monoclonal gammopathy of undetermined significance (MGUS), and often a …
named monoclonal gammopathy of undetermined significance (MGUS), and often a …
Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma
N Weinhold, C Ashby, L Rasche… - Blood, The Journal …, 2016 - ashpublications.org
To elucidate the mechanisms underlying relapse from chemotherapy in multiple myeloma,
we performed a longitudinal study of 33 patients entered into Total Therapy protocols …
we performed a longitudinal study of 33 patients entered into Total Therapy protocols …